Omar Hoseá Cabrera

Omar Hoseá Cabrera

Auto-generated profile, based on publicly available information

Omar Hoseá Cabrera

Department of Anesthesiology, University of Colorado School of Medicine, Aurora, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
KSKatie J. Schenning
Katie J. Schenning
KNKevin Noguchi
Kevin Noguchi
LMLauren Drew Martin
Lauren Drew Martin
FMFrancesca M. Manzella
Francesca M. Manzella
OCOmar H. Cabrera
Omar H. Cabrera
ABAnsgar M. Brambrink
Ansgar M. Brambrink

6 September 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
OCO. H. Cabrera
O. H. Cabrera
VTV. Tesic
V. Tesic
QTQ. L. Tat
Q. L. Tat
SCS. Chastain
S. Chastain
NQN. Quillinan
N. Quillinan
VJV. Jevtovic-Todorovic
V. Jevtovic-Todorovic

12 September 2019 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
SCShelby E. Chastain-Potts
Shelby E. Chastain-Potts
VTVesna Tesic
Vesna Tesic
QTQuy L. Tat
Quy L. Tat
OCOmar H. Cabrera
Omar H. Cabrera
NQNidia Quillinan
Nidia Quillinan
VJVesna Jevtovic-Todorovic
Vesna Jevtovic-Todorovic
Large body of animal work and emerging clinical findings have suggested that early exposure to anesthetics may result in increased risk of learning disabilities and behavioral impairments. Recent studies have begun to investigate anesthesia-induced epigenetic modifications to elucidate their role in behavioral and neurodevelopmental abnormalities. Here we examine sevoflurane-induced transgenerational modifications of subicular neuronal DNA methylation and expression of immediate early genes (IEGs), arc and junB, crucial to synaptic plasticity and normal neuronal development. We show that 6 h sevoflurane exposure in postnatal day 7 rat pups resulted in decreased neuronal 5-methycytosine, indicating reduced DNA methylation. This effect is transgenerationally expressed in offspring born to exposed mothers which is of importance considering that decreased DNA methylation in the brain has been linked with functional decline in learning and memory. We further show that sevoflurane exposure induces upregulation of Arc and JunB mRNA expression, 42.7% and 35.2%, respectively. Transgenerational changes in Arc and JunB mRNA were sexually dimorphic only occurring in males born to exposed females, expressed as upregulation of Arc and JunB mRNA, 71.6% and 74.0%, respectively. We further investigated correlation between altered arc promoter methylation and observed upregulation of Arc mRNA and observed that sevoflurane reduced methylation in the 5-upstream promoter region of females exposed to sevoflurane. Transgenerational hypomethylation and modifications to IEGs crucial to synaptic plasticity, observed following neonatal sevoflurane exposure could contribute to morphological and cognitive deficits known to occur with neonatal sevoflurane exposure.

7 December 2016 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
OCOmar Hoseá Cabrera
Omar Hoseá Cabrera
SOShawn David O’cOnnor
Shawn David O’cOnnor
BSBrant Stephen Swiney
Brant Stephen Swiney
PSPatricia Salinas-Contreras
Patricia Salinas-Contreras
FMFrancesca Maria Manzella
Francesca Maria Manzella
KNKevin Noguchi
Kevin Noguchi
Objectives: Caffeine (CAF) and sedative/anesthetic drugs (SADs) are often coadministered to premature infants in the neonatal intensive care unit (NICU). While SAD neurotoxicity in the developing brain is well established, it is not fully clear whether CAF interacts with SADs and whether this interaction is detrimental. Using a mouse model of prematurity, we hypothesized that CAF would increase apoptotic neurotoxicity when coadministered with SADs. Methods: Postnatal day 3 mice were treated with vehicle or 80 mg/kg CAF prior to challenge with 6 mg/kg midazolam, 40 mg/kg ketamine, or 40 μg/kg fentanyl. Six hours later, pups were sacrificed for activated caspase 3 (AC3) immunohistochemistry, and number of AC3 positive cells per mm3 throughout neocortex, hippocampus, caudate, thalamus, and colliculi was analyzed. Results: CAF caused a statistically significant increase in AC3 positive cells when coadministered with midazolam (p = 0.002), ketamine (p = 0.014), or fentanyl (p < 0.001). Our composite dataset suggests that the addition of CAF to these SADs has a supra-additive effect, causing more neurotoxicity than expected. Conclusions: CAF may augment the neurotoxic action of SADs indicated for neonatal sedation/anesthesia in the NICU by triggering widespread apoptosis in the developing brains of premature infants.

1 November 2015 in Neurobiology of Disease
Verified
Journal Article
Closed access
KNKevin Noguchi
Kevin Noguchi
OCOmar Hoseá Cabrera
Omar Hoseá Cabrera
BSBrant S. Swiney
Brant S. Swiney
PSPatricia Salinas-Contreras
Patricia Salinas-Contreras
JSJulie Kathryn Smith
Julie Kathryn Smith
NFNuri B. Farber
Nuri B. Farber

6 February 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SOShawn David O’cOnnor
Shawn David O’cOnnor
OCOmar Hoseá Cabrera
Omar Hoseá Cabrera
JDJoseph D. Dougherty
Joseph D. Dougherty
SSSukrit Singh
Sukrit Singh
BSBrant Stephen Swiney
Brant Stephen Swiney
KNKevin Noguchi
Kevin Noguchi
Objectives: Glucocorticoids (GCs) are used to improve respiratory mechanics in preterm infants despite clinical evidence linking neonatal GC therapy to cerebellar pathology. In developing mouse cerebellum, the GC dexamethasone (DEX) causes rapid GC-induced neural progenitor cell apoptosis (GINA). Focusing on pharmacological neuroprotection strategies, we investigated whether dexmedetomidine (DMT) protects against GINA. Methods: Neonatal mice were pretreated with DMT prior to DEX challenge. Additionally, we tested clonidine and yohimbine in vivo to determine mechanism of DMT neuroprotection. For in vitro studies, cerebellar neural progenitor cells were pretreated with DMT before DEX challenge. Results: In vivo, DMT attenuated GINA at 1 μg/kg and above, p < 0.0001. Clonidine significantly attenuated GINA, p < 0.0001, while yohimbine reversed DMT neuroprotection, p < 0.0001, suggesting DMT neuroprotection is likely mediated via adrenergic signaling. In vitro, DMT neuroprotection was achieved at 10 μM and above, p < 0.001, indicating DMT rescue is cell autonomous. Conclusions: DMT affords dose-dependent neuroprotection from GINA at clinically relevant doses, an effect that is cell autonomous and likely mediated by α2 adrenergic receptor agonism. DMT co-administration with GCs may be an effective strategy to protect the neonatal brain from GINA while retaining the beneficial effects of GCs on respiratory mechanics.